Sativus Tech pivots to automated saffron but warns of going-concern amid heavy convertible debt

Sativus Tech Corp. (PINK: SATT)

What's happening inside: The company has pivoted to its Saffron-Tech subsidiary to develop automated, vertically-farmed saffron. Saffron Tech is in advanced R&D and pilot stages (Ganei Tal pilot, POC in Korea with Dreamtech). Management is conserving cash, pursuing additional equity/debt financing, and the auditors flagged substantial doubt about the company's ability to continue as a going concern.

Key facts & statistics (all $ amounts are in thousands per the filing):

* Shares outstanding: 4,215,571 (as of Aug 14, 2025)

* Total assets: $616k (June 30, 2025)

* Cash & cash equivalents: $241k (up from $96k at Dec 31, 2024)

* Total current liabilities: $3,768k

* Convertible loans (current): $2,370k

* Fair value of convertible component: $696k

* Accumulated deficit: $(23,941)k

* Shareholders' deficit (equity): $(3,152)k

* Working capital deficit: $(3,499)k (per management)

* Three months ended June 30, 2025 - Operating loss: $213k; Financial expense (net): $209k; Net loss: $422k; Net loss attributable to equity holders: $332k; Loss per share: $(0.08)

* Six months ended June 30, 2025 - Net loss: $520k; Financial expense (net): $47k; Loss per share: $(0.08)

* Financial revaluation hit (convertible features) - three months ended June 30, 2025: $(214)k vs $(2,514)k in prior-year quarter (large improvement)

Positive points

* Active product focus and visible milestones: pilot site in Israel, successful POC reported in Korea and test cycles completed-product is at proof-of-concept / pilot commercialization stage.

* Cash position improved to $241k from $96k year-to-date; operating cash outflow reduced - net cash used in operations was $86k in the six months.

* Financial expense pressure eased materially vs prior year due to smaller negative revaluations of convertible instruments (major reduction from 2024)

* R&D spending remains steady (six months: $328k in 2025 vs $324k in 2024) - company continuing product development rather than cutting R&D entirely.

Negative points (income statement & related risks)

* Recurring losses: six-month net loss $520k; three-month net loss $422k. Accumulated deficit of $23,941k - long history of losses.

* Heavy burden from convertible debt: $2.37M of convertible loans and $696k fair-value conversion liability - these instruments create potential dilution and mark-to-market volatility (revaluations flow through P&L).

* Working capital and liquidity strain: working capital deficit $3.499M and restricted reliance on new financing; management states additional financing is required and failure to obtain it could force suspension/cessation of operations.

* Going concern: auditors included explanatory paragraph; management explicitly states substantial doubt about going concern.

* Internal control weaknesses flagged: disclosure controls & procedures were reported as not effective, increasing operational/reporting risk.

* Related-party payables and loans exist; potential governance / related-party risk.

Bottom line / short outlook

* Sativus (PINK: SATT) is a development-stage, majority-owner of Saffron-Tech and is progressing technical milestones (POC, pilot). Financially the company is fragile: limited cash ($241k), sizable convertible debt, negative working capital, and a going-concern warning. The improvement in convertible revaluation expense and lower net loss per share vs prior year are positive signs, but the company remains highly dependent on near-term financing and continued R&D success. For investors, risk is high: follow financing announcements, conversion/extension of convertible loans, pilot-to-commercial rollout progress, and any auditor/controls remediation updates.

Data source: Sativus Tech Corp. Form 10‑Q for quarter ended June 30, 2025 (figures as reported in the filing).